Medinol

Medinol is a privately-held cardiovascular medical device company founded in 1992 by Dr. Judith Richter and Dr. Jacob (Kobi) Richter. Since its founding, Medinol has pioneered new stent system technology, backed by over 400 patents, and has delivered over 2,000,000 stents to date. Its activities — including research, development, quality control, regulatory affairs, clinical trials, manufacturing, marketing, and sales — are conducted in-house. The company's product portfolio includes the EluNIR and EluNIR-PERL Ridaforolimus Eluting Coronary Stent Systems, alongside pipeline products such as IoNIR, ChampioNIR, and Xemed.

Medinol was founded in 1992 by Dr. Judith Richter and Dr. Jacob (Kobi) Richter. The company pioneered the NIR stent, first introduced in 1996, which was the first stent to provide both flexibility and robust scaffolding, enabling treatment of longer lesions in more complex anatomies. Since 1995, NIR and its successors have been examined in over 25 clinical studies involving more than 5000 patients. Medinol has delivered over 2,000,000 stents to date and holds over 400 patents. Its product line has advanced through generations, including the sixth-generation EluNIR and seventh-generation EluNIR-PERL Ridaforolimus Eluting Coronary Stent Systems.

Pioneering cardiovascular intervention technology with in-house research, development, and manufacturing.

• EluNIR Ridaforolimus Eluting Coronary Stent System

  Medinol's sixth generation coronary stent featuring a unique stent design which utilizes a distinctive CoCr framework composed of alternate strut widths, uniformly coated with an elastomeric coating and a Rapamycin analog drug.

• EluNIR – PERL Ridaforolimus Eluting Coronary Stent System

  Medinol's most recent advancement in coronary stent technology, a seventh-generation stent featuring a unique stent design which utilizes a distinctive CoCr framework composed of struts with varying widths and integrates radiopaque markers into its structure.

1. 1Cardiovascular medical devices: Stent manufacturer | Medinolmedinol.com
2. 2About Medinol Group, Pioneers In Cardiovascular Medical Devicesmedinol.com
3. 3Overview - Medinolmedinol.com
4. 4Drug Eluting Stent: The Future Of Coronary Stent System | Medinolmedinol.com